Amide Technologies is a biotech startup offering on-demand complex peptide manufacturing at unprecedented speed. Through its novel manufacturing platform developed at MIT, Amide is bridging the gap between traditional solid phase peptide synthesis and biological expression, empowering scientists on the cutting edge of peptide drug design.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
12/14/23	$16,500,000	Seed and Series A	Biological Engineering Ventures Engine Ventures Forcefield Venture Fund	undisclosed